From Prototype to Product: Pitfalls and Possibilities
AmplifiDx is developing a high-performance, low-cost microfluidic cartridge-based point-of-care testing system. The speaker will describe how the company has distinguished itself in an extremely crowded space, and how it continues to defy the odds even in this challenging economy for start-ups. This involves differentiated technology, but more importantly, creative partnerships and an understanding of the market.
Nancy Schoenbrunner, CEO of AmplifiDx, has a proven track record as an executive in the medical device and diagnostic field (Roche Diagnostics for 20 years; Scipher Medicine for 2 years). Nancy is adept at planning and directing the organization’s technology commercialization and innovation strategy, R&D and IP portfolio. She has experience in creating value by managing cross-functional global teams, managing external development partners, forming strategic alliances, and driving product innovation. She has a Ph.D. in Biophysics and is inventor on 31 issued and pending patent families. She has executed multiple successful commercialization projects from concept to market resulting in multiple first in class diagnostic product approvals including: • the cobas® EGFR cancer test (liquid biopsy), highlighted for innovation in the Roche annual reports in 2015 and 2016 • the cobas® 6800/8800 system, a top selling platform for Roche’s lab testing business (642M CHF revenue in 2017) • the cobas® Liat® point of care system, a major contributor to revenue growth for Roche in 2018 (>1500 system placements, 262% annual revenue growth). • Managing a team of data scientists to develop a predictive algorithm for treatment response in complex diseases, resulting in a clinically validated diagnostic product (PrismRA®) and numerous publications